Shanghai MicuRx Pharmaceutical Co (SHSE:688373) Debt-to-Equity : 0.93 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Shanghai MicuRx Pharmaceutical Co Debt-to-Equity?

Shanghai MicuRx Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥133.4 Mil. Shanghai MicuRx Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥224.4 Mil. Shanghai MicuRx Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥384.3 Mil. Shanghai MicuRx Pharmaceutical Co's debt to equity for the quarter that ended in Mar. 2025 was 0.93.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity or its related term are showing as below:

SHSE:688373' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.3 Max: 0.93
Current: 0.93

During the past 7 years, the highest Debt-to-Equity Ratio of Shanghai MicuRx Pharmaceutical Co was 0.93. The lowest was 0.01. And the median was 0.30.

SHSE:688373's Debt-to-Equity is ranked worse than
84.96% of 818 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs SHSE:688373: 0.93

Shanghai MicuRx Pharmaceutical Co Debt-to-Equity Historical Data

The historical data trend for Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicuRx Pharmaceutical Co Debt-to-Equity Chart

Shanghai MicuRx Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.37

0.19

0.27

0.69

Shanghai MicuRx Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.33	0.41	0.54	0.69	0.93

Competitive Comparison of Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Shanghai MicuRx Pharmaceutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai MicuRx Pharmaceutical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(105.742	+	196.118)	/	438.964
	=	0.69

Shanghai MicuRx Pharmaceutical Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(133.443	+	224.397)	/	384.321
	=	0.93

Shanghai MicuRx Pharmaceutical Co (SHSE:688373) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Shanghai MicuRx Pharmaceutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai MicuRx Pharmaceutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai MicuRx Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai MicuRx Pharmaceutical Co Ltd (SHSE:688373) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 53 Edison Road, Building 101 and 2, Floor 1-4, Building 1, Pilot Free Trade Zone, Shanghai, CHN, 201210

Website

http://www.micurxchina.com

Shanghai MicuRx Pharmaceutical Co Ltd is engaged in the discovery, development and commercialization of innovative medicines for unmet clinical needs.

Executives

	Director, core technical staff
Zhao Dong Ming	senior management
Yuan Hong	senior management
Wang Xing Hai	Senior management, core technical personnel
Li Zhi Le	Director

Shanghai MicuRx Pharmaceutical Co Headlines

No Headlines